The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kelley John P since 2007.
The trader's CIK number is 1310470.
At the time of the last reporting, Kelley John P was the President and COO of Acorda Therapeutics Inc. (stock ticker symbol ACOR).
Also see all insider trading activities at Acorda Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | MDCO | 3,000 | $45,570 | 50,000 | $1,595,250 | 50,000 | $913,500 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ACOR | 0 | $0 | 10,000 | $440,000 | 10,000 | $254,500 |
| 2014 | ACOR | 0 | $0 | 10,000 | $400,000 | 10,000 | $167,399 |
| 2013 | ACOR | 0 | $0 | 15,000 | $570,000 | 15,000 | $251,099 |
2. Acorda Therapeutics Inc (ACOR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-08-03 | MDCO | Buy | 3,000 | 15.19 | 45,570 |
| 2007-01-03 | MDCO | Sale | 50,000 | 31.91 | 1,595,250 |
| 2007-01-03 | MDCO | Option Ex | 50,000 | 18.27 | 913,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-01-13 | ACOR | Sale | 10,000 | 44.00 | 440,000 |
| 2015-01-13 | ACOR | Option Ex | 10,000 | 25.45 | 254,500 |
| 2014-12-18 | ACOR | Option Ex | 10,000 | 16.74 | 167,399 |
| 2014-12-18 | ACOR | Sale | 10,000 | 40.00 | 400,000 |
| 2013-08-02 | ACOR | Option Ex | 15,000 | 16.74 | 251,099 |
| 2013-08-02 | ACOR | Sale | 15,000 | 38.00 | 570,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelley John P (President and COO of Acorda Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.